The blood-brain barrier (BBB) maintains the optimal microenvironment in the central nervous system (CNS) for proper brain function. The BBB comprises specialized CNS endothelial cells with fundamental molecular properties essential for the function and integrity of the BBB. The restrictive nature of the BBB hinders the delivery of therapeutics for many neurological disorders. In addition, recent evidence shows that BBB dysfunction can precede or hasten the progression of several neurological diseases. Despite the physiological significance of the BBB in health and disease, major discoveries of the molecular regulators of BBB formation and function have occurred only recently. This review highlights recent findings describing the molecular determinants and core cellular pathways that confer BBB properties on CNS endothelial cells.
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History of the BBB
The BBB (see Glossary) partitions the brain from circulating blood and functions to: (i) shield the brain from potential blood-borne toxins; (ii) meet the metabolic demands of the brain; and (iii) regulate the homeostatic environment in the CNS for proper neuronal function [1] . The functional BBB comprises CNS endothelial cells, pericytes, astrocytes, and neurons that collectively form a functional 'neurovascular unit' (NVU) ( Figure 1) [2].
The BBB was first observed over a century ago. Pioneering physiologists studying the cerebrospinal fluid (CSF) noticed that water-soluble dyes injected in the peripheral circulation stained several tissues except the brain [3] . Ehrlich argued that this phenomenon occurred because the CNS had low affinity for the dye [4] . However, Goldmann questioned this argument, as injection of the same dyes in the subarachnoid space colored the brain but not peripheral tissues [5] . Continuing from these studies, Lina Stern and colleagues performed experiments in which they injected several vehicles into the brain parenchyma and blood. The results from these dye studies prompted Stern to introduce the term 'blood-brain barrier' and suggest its physiological function in maintaining brain homeostasis [6] . Over the years, the concept of the BBB fascinated physiologists but the anatomical site of the BBB was highly disputed; specific possibilities included the endothelium, astrocytic end-feet, and the basement membrane. A seminal study by Reese and Karnovsky using electron microscopy (EM) and injection of electron-dense horseradish peroxidase (HRP) resolved this dispute [7] . In this work, ultrastructural analysis by EM was used to delineate astrocytic end-feet and the luminal, abluminal, and basement membrane. Results revealed that the HRP was confined to the lumen of the CNS endothelium. Furthermore, EM revealed that the CNS endothelial cells are joined continuously by tight junction complexes and have limited intracellular vesicles [7] . Similar to Goldman's experiments, HRP injected into the brain parenchyma diffused past astrocytic end-feet and halted at the abluminal membrane of the endothelium, demonstrating that astrocytic end-feet do not significantly contribute to the physical barrier [8] . Thus, the site
Trends
The BBB comprises CNS endothelial cells that display specialized molecular properties essential for BBB function and integrity.
These molecular BBB properties are not intrinsic to CNS endothelial cells but have to be induced by the environment.
The formation, function, and maintenance of the BBB require functional interaction between CNS endothelial cells and NVUs.
Advances in gene profiling and celltype purification methods have progressed the identification of the molecular mediators and core cellular pathways involved in BBB function and integrity.
A comprehensive understanding of the key molecules and cellular pathways involved in BBB function would offer novel strategies for CNS therapeutics. 
Department of

